get him. >> what could soriot bring to the table at teva? he's been making a big bet on cancer immunotherapy >> he brings a quality of understanding that is required to be successful in pharmaceutical although teva is known as a generics company, it actually has a subscription business as well and it's looking to grow that business. they got very good r&d and i think what he can do potentially if this is true again is bring some of that r&d decision making and discipline and quality into te teva at a time when it needs to keep the generics going but also potentially build its business through the prescription side of things so i think it's a great challenge to take on to bimd up teva in the likes of a full pharmaceutical company >> john, thank you so much for your insight this morning. really appreciate it just want to bring you breaking news quite account an interesting poll when it comes to the expectations for china's gdp it's third quarter growth is seen to be slowing keep in mind that the government's own forecast is for 6.5% >>> still

and shares of teva getting a pop on reports that the company will poach rival astrazeneca's ceo. shares of astrazeneca moving lower on that report but again teva up 2.5% mallinckrodt getting some attention. the fda grarntinting the compan special status for a muscular dystrophy drugs. daimler under pressure, a new report says that the carmaker possibly sold more than a million cars with excess emissions throughout europe and the united states. >>> maker of havaiana being sold for $1.1 billion it was owned by jnf group which manages the fortune of the about a batista family and the center of the country's corruption scandal. the maker is being bought by three brazilian banking groups >> everyone from blake lively to january fer jennifer aniston wears these green flip-flops and it urge issed on t esed sur expectation of the sale. so it was more about the brand itself that resonates with a lot of people. why? well,ing they are cool and they are green and they are comfortable. >> but flip-flops. it's a piece of rubber >> the power of branding and marketing. >> i know. there we go. i

shares of teva down roughly 4% at 31.90. and shares of a ten networks fell after the company shook investor last night with its preliminary result. weaker performance in its north america and japan markets would cause sales this quarter to come in nearly $10 million lighter than expected. the company said profit would come up short and shares of a ten did today, plunlging 16% to 6.95. >>> it is time for our market monitor, who has names of three companies he said raise dividends at a higher rate, last time he was on this september, he recommended american tower, which was up 20%. higher by 6% and cvs, down by 13%. joining us is mark spellman, manager at alpine fund. welcome back. nice to have you here. sfwl thank you very much. let's get to your picks because one is still on the list and that is lowe's. adding to positions here. >> yeah, lowe's has started tout year doing very well. i think somewhat at the expense of sears when it comes to appliance sales, but in the last month, they've been caught up in amazon is is talking

it has come at a bit of a funny time, leaving to teva would be a bit of a shock move, the generic truckes it mean for the future for astrazeneca? oil prices steady in today. what has caused that, because we have seen a recent slide, haven't we? worries about supply are always there with oil. with opec in particular saying we're not going to produce any more, we're not going to produce any more, we all agree we are not going to produce any more, and then gradually all countries start producing more than they said they were going to. it has happened again and again. people are saying the cartel is opec it is broken, that is what has caused oil prices to fall. thank you. let's take a quick look at the picture on wall street quite a solid opening — following some good chinese trade data and upbeat commentary from target that boosted retailer shares. chinese exports and imports injune outstripped expectations, suggesting stronger growth in the world's second largest economy. that's all from me, there is a round—up of all the other top business stories on our website — bbc.co.uk/business a fe

teva has 4,000 employees in israel alone. >>> and ferrare a making a bid into nestle candy business theyake sweets like now and later and lemon heads. units include butter finger, baby ruth, sweet tarts, race soe iconic brands. older world products that could have some new portfolio products. >> i love butter finger. >> raise in ets at the movies. used to like them as a kid >>> more stocks to watch phillips second quarter profit rose 36% the company maintaining outlook for the year, despite volatility in many markets. phillips is launching more than $1.7 billion buy back shares are up more than 3%. now mitsubishi will bay $39 a share, to the friday closing price. they started clinical trials for parkinson's disease that could launch in 2019 neuroderm shares up. >>> the company reports a drop in second quarter sales after cyber attack disrupted it. 2% target for sales growth will be challenging talking about this company a lot. shares down about 1% in early trading. >>> still to come, details of favoritism scandal taking a toll on his approval rating. >>> check out early action in europe

executive hands -- pla ns to jump ship from the drugmaker to take the top job in israel's struggling teva marta circles industry -- pharmaceuticals company. how it's narrowed since before the french election when the yield spread was 80 basis points, the widest in 2012. we've come down to roughly 25 basis points. will expectations macron unveil structural reforms that with potential tapering of bond purchases by the european central bank around the corner, j.p. morgan chase says this spread may widen. keep an eye on that. one year anniversary, you know what. one year since theresa may became the u.k. prime minister. showing you how the main u.k. acid stared under theresa may. that's the ftse 100. the falling pound boosted exporters. sterling index down by 2.9%. that's the blue line. andy bloomberg sovereign bond index for the u.k. is down by 2.6%. the asset class to be in under may is very much stocks. the big question is, will she still be pm in a year. vonnie: it's crazy how fast a year goes by. i'm sure she's celebrating a bittersweet anniversary in some ways rate health care in focus

in the meantime, let's talk about a few more stocks that are up teva is up 1%. what's going on? >> it's one of those perpetual value companies. ho look, i still think this is a challenged landscape but this is a decent story. >> pete, seagate was downgraded. >> western digital is winning in this battle and i think a lot of that has to do with the acquisition strategy that is spot on. hitting near the lows of the 52 weeks for this name. i'd stay away from seagate i think western digital goes to a hundred. >> the google of russia, also known as yandex -- >> i don't know russia, scott. i have nothing in russia >> you're huge in russia >> look, listen, listen, it's a technology company that has a search platform. when you look at how it trades relative to the rsx, which is the russia etf, they move in lockstep it's essentially a proxy i'm just saying how it moves uber got chased out. maybe they will let yandex run it i don't know that i would buy yandex this is not my time of thing. >> joe, t. rowe. >> up 5% to 906 million. asset managers the last couple of years have struggled as t

i'm looking at teva pharmaceutical that wasn't so great when you see this lower end you can see the trajectoryeeing today is the august 30 puts being bought. here's what i'm going to tell you. i'm not in this trade, but i'll tell you this. i think they're buying this puts not because they think that stock is going to pull back, i think they're buying it to protect against the position that was put on over the last couple of weeks. when i saw the volumes, there were days when we had volumes way past anything close to a three-month normal so because of that, i think they're buying protection, expecting this stock to go even higher if you were lucky to buy this thing around that 30 to 32 range, stock is going to go a little bit higher. we talk about protecting all the time this is exactly what we're talking about, a protecting position >> just like with morgan stanley, with jpmorgan, with goldman, last week, on the financial side i think this is the same sort of thing that pete's talking about. >> gotcha, guys. come on back this way. now more to be that situation developing in north korea. the ro

shares of teva pharmaceuticals getting a pop on reports they will poach rival astra zeneca's ceo.re down lower on that news. >>> president trump arriving in france joining french president emmanuel macron for a news conference later today joining us is p.j. crowley, former assistant secretary of state in the obama administration and author of "red line, american foreign policy in a time of fractured politics and failing states. good morning to you. >> good morning. >> thanks for joining us i guess the first question is, is how popular or unpopular is president trump in france at the moment >> he's very deeply unpopular in france and this presents an interesting conundrum for president macron on the one hand the politics would suggest that he should push and prod president trump on climate and other issues when they're together in public later in the day on the other hand, he has the opportunity to become kind of the trump whisperer in europe. under george w. bush you had a great relationship with tony blair. with barack obama, it was angela merkel so who's going to step up and kin

that report is coming out from an israeli publication you see teva is up there we reached out to bothwe have not heard back yet from astrazeneca rumors that astrazeneca is planning to stay on the company. we'll bring it back tow. >> thank you very much >>> another high for the s&p 500 and the dow. >> joining us of what is another good week for equity, mark >> take a look at the dow leadership microsoft is leading right now and we are seeing new hospitalized all over the place and facebook and pain pail and also up there and walmart is doing wet. apple is not high but it is moving up. we are talking about the earnings overall, it is so good. there are two issues for r the banks right now verses the fundamentals we had rather crummy numbers here on the inflation numbers and the cpi numbers and that means inflation is not really there. that means the bars have moved down today the banks would have been down today regardless if they had easte earnings or not. this information is provided to us by our partners one month before, banks tend to trade up the day that jp morgan tends to trail d